Cox Emily R, Plotnikoff Ronald C, Gibson Peter G, Keating Shelley E, Acharya Shamasunder, Lewthwaite Hayley
Centre for Active Living and Learning, University of Newcastle, Callaghan, New South Wales, Australia; Active Living and Learning Research Program, Hunter Medical Research Institute, New Lambton, New South Wales, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia.
Centre for Active Living and Learning, University of Newcastle, Callaghan, New South Wales, Australia; Active Living and Learning Research Program, Hunter Medical Research Institute, New Lambton, New South Wales, Australia; School of Education, University of Newcastle, Callaghan, New South Wales, Australia.
Can J Diabetes. 2024 Dec;48(8):493-501.e5. doi: 10.1016/j.jcjd.2024.08.004. Epub 2024 Aug 17.
The aim of this research was to understand the prevalence and impact of long COVID on adults with type 2 diabetes (T2D). Specifically, we sought to identify the proportion of adults with T2D who have had COVID-19 and experienced long COVID symptoms. We also explored how these ongoing symptoms impact diabetes management and physical activity participation.
Our study was carried out using an online survey of adults in Australia with T2D who had confirmed COVID-19 ≥12 weeks before participation. Respondents were asked to report the presence (and severity) of long COVID symptoms, and, for those with long COVID, the impact of their symptoms on diabetes management (blood glucose, body weight) and physical activity participation (activities of daily living, work/study, exercise).
Survey responses were provided by 1,046 adults with T2D (median age 61.0 [interquartile range 49.8 to 70.0] years; 56.0% men, 42.1% women, and 1% nonbinary/transgender; median T2D duration 10.0 [5.0 to 18.0] years and median time since COVID-19 infection 33.0 [20.3 to 36.1] weeks). Almost one-third (30%) of respondents reported long COVID symptoms (present ≥12 weeks after most recent infection); 40% of respondents with long COVID symptoms reported a worsening of their diabetes management since their COVID-19 infection, with 29% reporting trouble controlling their blood glucose and 43% reporting a higher body weight. Two-thirds of respondents with ongoing symptoms reported that these symptoms moderately to severely impacted their ability to perform activities of daily living, work, and/or exercise. The majority of those with long COVID reported reducing the frequency, duration, and/or intensity of exercise since their COVID-19 infection, with 36.1% not yet returning to their preinfection exercise levels; 66% cited ongoing symptoms as the primary reason for these limitations.
Physical activity is a crucial component of diabetes management. However, the high prevalence of long COVID is hindering participation in this population, as well as deleteriously impacting diabetes management. Developing strategies to support adults with T2D and long COVID to recommence safe levels of physical activity is of critical importance.
本研究旨在了解新冠后长期症状(long COVID)在2型糖尿病(T2D)成人患者中的患病率及其影响。具体而言,我们试图确定感染过新冠病毒并出现新冠后长期症状的T2D成人患者的比例。我们还探讨了这些持续症状如何影响糖尿病管理和体育活动参与情况。
我们对澳大利亚确诊感染新冠病毒且在参与研究前至少12周的T2D成人患者进行了在线调查。受访者被要求报告新冠后长期症状的存在情况(及其严重程度),对于有新冠后长期症状的患者,还需报告这些症状对糖尿病管理(血糖、体重)和体育活动参与情况(日常生活活动、工作/学习、锻炼)的影响。
1046名T2D成人患者提供了调查回复(中位年龄61.0岁[四分位间距49.8至70.0岁];男性占56.0%,女性占42.1%,非二元/跨性别者占1%;T2D中位病程10.0年[5.0至18.0年],自新冠病毒感染后的中位时间为33.0周[20.3至36.1周])。近三分之一(30%)的受访者报告有新冠后长期症状(在最近一次感染后持续出现≥12周);40%有新冠后长期症状的受访者报告自新冠病毒感染后糖尿病管理情况恶化,其中29%报告血糖控制困难,43%报告体重增加。三分之二有持续症状的受访者表示,这些症状对他们进行日常生活活动、工作和/或锻炼的能力有中度至重度影响。大多数有新冠后长期症状的受访者报告自新冠病毒感染后减少了锻炼的频率、时长和/或强度,36.1%的人尚未恢复到感染前的锻炼水平;66%的人将持续症状作为这些限制的主要原因。
体育活动是糖尿病管理的关键组成部分。然而,新冠后长期症状的高患病率阻碍了该人群参与体育活动,同时也对糖尿病管理产生了有害影响。制定策略以支持患有T2D和新冠后长期症状的成年人重新开始安全水平的体育活动至关重要。